ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,837, issued on June 10, was assigned to ALMAC DISCOVERY Ltd. (Craigavon, Great Britain).
"ROR1-specific antigen binding molecules" was invented by Estelle Grace McLean (Craigavon, Great Britain), Paul Richard Trumper (Craigavon, Great Britain), Jennifer Thom (Craigavon, Great Britain), Timothy Harrison (Craigavon, Great Britain), Graham John Cotton (Craigavon, Great Britain), Caroline Barelle (Craigavon, Great Britain), Andrew Porter (Craigavon, Great Britain) and Marina Kovaleva (Craigavon, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to receptor tyrosine kinase-like orphan receptor 1 (ROR1) specific an...